RPS6KB1 and ovarian carcinoma: Consistent with these studies, our results showed that pharmacological inhibition of AMPK by compound C in siNANOG‐transfected ovarian cancer cells increased the phosphorylation of mTOR and p70S6K and reversed the effects of NANOG knockdown.